Teprotumumab for Inactive Thyroid Eye Disease? The Jury Is Still Out.

被引：0
|
作者：
Dosiou, Chrysoula [1 ,2 ]
机构：
[1] Stanford Univ, Div Endocrinol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Div Endocrinol, Sch Med, 300 Pasteur Dr,S025, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2024年 / 109卷 / 09期
关键词：
thyroid eye disease; teprotumumab; MANAGEMENT;
D O I：
10.1210/clinem/dgae052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e1802 / e1803
页数：2
相关论文
共 50 条
  • [41] Evaluation of the efficacy, safety, and durability of teprotumumab in thyroid eye disease
    Mechels, Keegan
    Hwang, Catherine
    Perry, Julian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [42] Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
    Allen, Richard C.
    Bradley, Elizabeth A.
    Fante, Robert G.
    Lucarelli, Mark J.
    OPHTHALMOLOGY, 2021, 128 (08) : 1125 - 1128
  • [43] Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease
    Hwang, Catherine J.
    Rebollo, Nicole P.
    Mechels, Keegan B.
    Perry, Julian D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 263 : 152 - 159
  • [44] The Effect of Teprotumumab on Ocular Surface Symptoms in Thyroid Eye Disease
    Cale, Mario
    Osias, Ethan
    Singh, Pallavi
    Rootman, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [45] Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease"
    Men, Clara J.
    Amarikwa, Linus
    Pham, Brandon
    Sears, Connie
    Clauss, Kevin
    Lee, Bradford W.
    Lee, Wendy W.
    Pasol, Joshua
    Ugradar, Shoaib
    Shinder, Roman
    Cockerham, Kimberly
    Wester, Sara
    Douglas, Raymond
    Kossler, Andrea Lora
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 111 - 112
  • [46] Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
    Sears, Connie M.
    Azad, Amee D.
    Amarikwa, Linus
    Pham, Brandon H.
    Men, Clara J.
    Kaplan, Daniel N.
    Liu, Jocelyn
    Hoffman, Andrew R.
    Swanson, Austin
    Alyono, Jennifer
    Lee, Jennifer Y.
    Dosiou, Chrysoula
    Kossler, Andrea L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 240 : 1 - 13
  • [47] The Effect of Teprotumumab on Eyelid Position in Patients with Thyroid Eye Disease
    Simmons, Brittany A.
    Tran, Charlene
    Pham, Chau M.
    Shriver, Erin M.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2022, 10 (04) : E4287
  • [48] The role of teprotumumab in chronic, clinically active thyroid eye disease
    Caroline Y. Yu
    Brittany A. Simmons
    Chau M. Pham
    Erin M. Shriver
    Eye, 2022, 36 : 1500 - 1501
  • [49] Teprotumumab improves light sensitivity in patients with thyroid eye disease
    Parunakian, Emanuil
    Ugradar, Shoaib
    Tolentino, Joseph
    Malkhasyan, Emil
    Raika, Pershanjit
    Ghaly, Joseph
    Bisht, Chirag
    Douglas, Raymond S.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (09) : 2999 - 3006
  • [50] Teprotumumab for thyroid eye disease: early response is not required for benefit
    Ugradar, Shoaib
    Wang, Yao
    Mester, Tunde
    Kahaly, George J.
    Douglas, Raymond S.
    EYE, 2022, 36 (07) : 1403 - 1408
12345